Evidence-based · Educational only
36+ Peptides indexed
Free research library
Free newsletter — subscribe below
★ = FDA-approved medical indication
Not medical advice — always consult a clinician
Evidence-based · Educational only
36+ Peptides indexed
Free research library
Free newsletter — subscribe below
★ = FDA-approved medical indication
Not medical advice — always consult a clinician
All peptides

Selank

Research / Investigational

Selank is a synthetic heptapeptide analog of tuftsin developed as an anxiolytic in Russia.

Buy Selank on American Peptides

Affiliate link — we may earn a commission at no extra cost to you.

Overview

Selank is a synthetic heptapeptide analog of tuftsin developed as an anxiolytic in Russia.

FDA Approval Status

Not approved by the FDA. Investigational or intended for research purposes only.

Mechanism of Action

Proposed effects on GABAergic and enkephalin systems.

Current Research

Russian clinical trials; not FDA-evaluated.
Research strength: Limited

Potential Medical Uses

  • Investigational only in the U.S.

Potential Benefits

  • Reported anxiolytic effects

Known Side Effects

  • Limited independent data

Contraindications

  • Unknown

Drug Interactions

  • CNS depressants (theoretical)

Administration Methods

  • Intranasal (research)

Half-life

Short

Reconstitution

N/A (nasal spray typical)

Storage & Handling

Refrigerate.

References & Sources

Frequently Asked Questions

Information on this page is educational and general in nature. It is not medical advice. Consult a qualified healthcare professional before making any medical decisions.